13.04

4.78% 0.595

Adaptive Biotechnologies Corp (ADPT)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt ADPT? Forum Prognose

Schlusskurs vom Vortag:

$12.45

Offen:

$13.05

24-Stunden-Volumen:

3.32M

Relative Volume:

1.56

Marktkapitalisierung:

$2.01B

Einnahmen:

$276.98M

Nettoeinkommen (Verlust:

$-59.46M

KGV:

-32.72

EPS:

-0.3987

Netto-Cashflow:

$-48.95M

1W Leistung:

-12.21%

1M Leistung:

-18.67%

6M Leistung:

+3.45%

1J Leistung:

+81.94%

1-Tages-Spanne:

$12.69

$13.28

1-Wochen-Bereich:

$12.00

$15.16

52-Wochen-Spanne:

$6.675

$20.76

Adaptive Biotechnologies Corp Stock (ADPT) Company Profile

Firmenname

Adaptive Biotechnologies Corp

Sektor

Healthcare (1118)

Branche

Biotechnology (616)

Telefon

206-659-0067

Adresse

1165 EASTLAKE AVE E, SEATTLE, WA

Mitarbeiter

624

Twitter

@adaptivebiotech

Nächster Verdiensttermin

2025-02-11

Neueste SEC-Einreichungen

ADPT's Discussions on Twitter

Compare ADPT vs VRTX, REGN, ARGX, ALNY, ONC

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
ADPT Adaptive Biotechnologies Corp	13.04	1.92B	276.98M	-59.46M	-48.95M	-0.3987
VRTX Vertex Pharmaceuticals Inc	469.98	121.46B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	743.45	78.93B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	700.42	43.87B	4.16B	1.29B	734.26M	19.59
ALNY Alnylam Pharmaceuticals Inc	313.47	42.07B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	283.88	31.65B	5.36B	287.73M	924.18M	2.5229

Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-12-02	Fortgesetzt	Morgan Stanley	Equal-Weight
2025-09-30	Eingeleitet	Guggenheim	Buy
2025-06-18	Eingeleitet	Craig Hallum	Buy
2025-03-21	Hochstufung	Goldman	Neutral → Buy
2023-07-05	Fortgesetzt	JP Morgan	Overweight
2023-01-05	Eingeleitet	Scotiabank	Sector Outperform
2022-12-21	Hochstufung	Piper Sandler	Neutral → Overweight
2022-08-25	Eingeleitet	Credit Suisse	Underperform
2022-06-03	Eingeleitet	Piper Sandler	Neutral
2022-02-16	Bestätigt	BTIG Research	Buy
2022-02-16	Bestätigt	BofA Securities	Buy
2022-02-16	Bestätigt	Goldman	Neutral
2022-02-16	Bestätigt	JP Morgan	Overweight
2021-10-15	Fortgesetzt	Cowen	Outperform
2021-03-03	Herabstufung	Goldman	Buy → Neutral
2020-10-08	Fortgesetzt	BTIG Research	Buy
2020-09-09	Eingeleitet	Morgan Stanley	Equal-Weight
2020-06-03	Eingeleitet	Goldman	Buy
2019-07-23	Eingeleitet	BTIG Research	Buy
2019-07-22	Eingeleitet	BofA/Merrill	Buy
2019-07-22	Eingeleitet	Cowen	Outperform
2019-07-22	Eingeleitet	Goldman	Neutral
2019-07-22	Eingeleitet	Guggenheim	Buy
2019-07-22	Eingeleitet	William Blair	Outperform

Alle ansehen

Adaptive Biotechnologies Corp Aktie (ADPT) Neueste Nachrichten

11:20 AM

Adaptive Biotechnologies (NASDAQ:ADPT) Shares Gap UpWhat's Next? - MarketBeat

11:20 AM

Mar 12, 2026

Adaptive Biotechnologies (NASDAQ:ADPT) Stock Price Down 9.9%Here's Why - MarketBeat

Mar 12, 2026

Mar 10, 2026

Piper Sandler reiterates Adeptus Biotechnologies stock rating at overweight By Investing.com - Investing.com India

Mar 10, 2026

Insider Selling: Adaptive Biotechnologies (NASDAQ:ADPT) COO Sells 19,460 Shares of Stock - MarketBeat

Mar 10, 2026

Piper Sandler reiterates Adeptus Biotechnologies stock rating at overweight - Investing.com

Mar 10, 2026

Mar 09, 2026

Lo Francis, chief people officer at Adaptive Biotechnologies, sells $574k in ADPT - Investing.com Nigeria

Mar 09, 2026

Mar 08, 2026

Do Insider Sales Align With Adaptive Biotechnologies' (ADPT) MRD-Driven Momentum and Long-Term Strategy? - simplywall.st

Mar 08, 2026

Mar 07, 2026

Adaptive Biotechnologies (NASDAQ:ADPT) Stock Rating Lowered by Wall Street Zen - MarketBeat

Mar 07, 2026

Mar 06, 2026

Loss Report: Will Adaptive Biotechnologies Corporation stock go up in YEAR - baoquankhu1.vn

Mar 06, 2026

Insider Sales Put Focus On Adaptive Biotechnologies Growth Story And Dilution Risk - Yahoo Finance

Mar 06, 2026

Mar 05, 2026

Adaptive Biotechnologies’ Rubinstein sells $1.49m in shares By Investing.com - Investing.com UK

Mar 05, 2026

Adaptive Biotechnologies’ Rubinstein sells $1.49m in shares - Investing.com Nigeria

Mar 05, 2026

Adaptive Biotechnologies Corp. Achieves 102.46% Yearly Gain, Establishing It as a Multibagger Stock - Markets Mojo

Mar 05, 2026

Amova Asset Management Americas Inc. Decreases Stake in Adaptive Biotechnologies Corporation $ADPT - MarketBeat

Mar 05, 2026

Mar 04, 2026

Insider Sell: Harlan Robins Sells 24,233 Shares of Adaptive Biot - GuruFocus

Mar 04, 2026

Adaptive Biotechnologies (NASDAQ:ADPT) Insider Harlan Robins Sells 10,000 Shares - MarketBeat

Mar 04, 2026

Adaptive Biotechnologies CSO Robins sells $392,329 in ADPT stock By Investing.com - Investing.com Australia

Mar 04, 2026

Adaptive Biotechnologies CSO Robins sells $392,329 in ADPT stock - Investing.com

Mar 04, 2026

Mar 03, 2026

Chad Robins Sells 289,024 Shares of Adaptive Biotechnologies (NASDAQ:ADPT) Stock - MarketBeat

Mar 03, 2026

Adaptive Biotechnologies (NASDAQ:ADPT) CEO Sells $823,848.16 in Stock - MarketBeat

Mar 03, 2026

Insider Sell: Chad Robins Sells 524,998 Shares of Adaptive Biote - GuruFocus

Mar 03, 2026

CEO of Adaptive Biotechnologies (NASDAQ: ADPT) sells 524,998 shares - Stock Titan

Mar 03, 2026

Adaptive Biotechnologies CEO Sells Over $8 Million in Company Stock - TradingView

Mar 03, 2026

A Look At Adaptive Biotechnologies (ADPT) Valuation As CEO Updates MRD Growth And Profitability Outlook - simplywall.st

Mar 03, 2026